Streetbeat News

Products Services

AOS

INDV

LILM

TSLA

Tesla's shares fell 5.6% in pre-market trading after a disappointing robotaxi unveiling event. Other stocks like A. O. Smith, Lilium, and Indivior also saw declines due to various reasons including lowered earnings forecasts and revenue guidance.

Portfolio Pulse from Avi Kapoor

October 11, 2024 | 12:40 pm

AGBA

FAST

TSLA

Tesla's stock dropped 7% after unveiling a 2-seater Cybercab and a 20-seater Robovan. AGBA's stock surged 34% on news of a merger with Triller, pending Nasdaq approval. Fastenal's stock rose 5% following better-than-expected Q3 results.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:39 pm

MANH

Windsor, a women's fashion retailer, has chosen Manhattan Associates' cloud-native POS system to enhance its customer experience across 300+ stores. The implementation aims to provide a seamless omnichannel shopping experience and is expected to complete this summer.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:33 pm

CATX

Perspective Therapeutics is advancing the development of its radiopharmaceutical therapy [212Pb]VMT01 following promising data presented at the Society for Melanoma Research Congress. The therapy showed safety and efficacy in heavily pretreated patients, with no dose-limiting toxicities and prolonged progression-free survival. The trial is now testing a lower dose to optimize treatment in melanoma, both as a monotherapy and in combination with Nivolumab.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:32 pm

CLS

Celestica has launched the DS4100 800G switch, designed to optimize AI and machine learning data center workloads. This new product could enhance Celestica's position in the tech industry, particularly in the AI and data center markets.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:16 pm

TSLA

Tesla's stock is experiencing a pullback due to investor disappointment following the 'We, Robot' event. The unveiling of the Cybercab, an autonomous vehicle, did not meet market expectations, and its production timeline is set for 2026 or later, causing concern among investors.

Portfolio Pulse from Shanthi Rexaline

October 11, 2024 | 12:10 pm

INNV

InnovAge Holding Corp. (NASDAQ:INNV) is set to present its clinical, operational, and business transformations at the 2024 National PACE Association Conference. As the largest PACE provider, InnovAge focuses on integrated care for seniors, enhancing operations under CEO Patrick Blair.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:06 pm

IRON

Disc Medicine is set to present new data from its Phase 1b trial of DISC-0974, a treatment for chronic kidney disease and anemia, at the 2024 American Society of Nephrology Kidney Week.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:05 pm

ACRV

Acrivon Therapeutics has dosed the first patient in its Phase 1 trial of ACR-2316, a novel WEE1/PKMYT1 inhibitor, two quarters ahead of schedule. The drug, designed using Acrivon's AP3 platform, aims for complete tumor regression and is expected to show initial clinical data in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:04 pm

BDMD

Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) reported a 13.8% increase in H1 2024 revenues to $13.1M and an 85.8% rise in net income to $4.4M. The company, a leading microwave ablation device provider, has expanded into the U.S. market.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 12:03 pm